06:00 UTC Charta Aetatis Cyberpunk

Newsletter Pro Sign in Early access Register
Aa · Display
Themes
Type size
Density
MorningStar Security is in early access. The wiki is open to everyone; the news desks open with a code. Have a code, or want launch notice?
Export
growing · 9 feeds

Ozempic

GLP-1 medication for weight management

News volume 5 stories in 90 days
22 Aug: 0 stories23 Aug: 0 stories24 Aug: 0 stories25 Aug: 0 stories26 Aug: 0 stories27 Aug: 0 stories28 Aug: 0 stories29 Aug: 0 stories30 Aug: 0 stories31 Aug: 0 stories1 Sep: 0 stories2 Sep: 0 stories3 Sep: 1 story4 Sep: 0 stories5 Sep: 0 stories6 Sep: 0 stories7 Sep: 0 stories8 Sep: 0 stories9 Sep: 0 stories10 Sep: 0 stories11 Sep: 0 stories12 Sep: 0 stories13 Sep: 0 stories14 Sep: 0 stories15 Sep: 0 stories16 Sep: 0 stories17 Sep: 0 stories18 Sep: 1 story19 Sep: 0 stories20 Sep: 0 stories21 Sep: 0 stories22 Sep: 0 stories23 Sep: 0 stories24 Sep: 0 stories25 Sep: 0 stories26 Sep: 0 stories27 Sep: 1 story28 Sep: 0 stories29 Sep: 1 story30 Sep: 0 stories1 Oct: 0 stories2 Oct: 0 stories3 Oct: 0 stories4 Oct: 0 stories5 Oct: 0 stories6 Oct: 0 stories7 Oct: 0 stories8 Oct: 0 stories9 Oct: 0 stories10 Oct: 0 stories11 Oct: 0 stories12 Oct: 0 stories13 Oct: 0 stories14 Oct: 0 stories15 Oct: 0 stories16 Oct: 0 stories17 Oct: 0 stories18 Oct: 0 stories19 Oct: 0 stories20 Oct: 0 stories21 Oct: 0 stories22 Oct: 0 stories23 Oct: 0 stories24 Oct: 0 stories25 Oct: 0 stories26 Oct: 0 stories27 Oct: 0 stories28 Oct: 0 stories29 Oct: 0 stories30 Oct: 0 stories31 Oct: 0 stories1 Nov: 0 stories2 Nov: 0 stories3 Nov: 0 stories4 Nov: 0 stories5 Nov: 0 stories6 Nov: 0 stories7 Nov: 0 stories8 Nov: 0 stories9 Nov: 0 stories10 Nov: 1 story11 Nov: 0 stories12 Nov: 0 stories13 Nov: 0 stories14 Nov: 0 stories15 Nov: 0 stories16 Nov: 0 stories17 Nov: 0 stories18 Nov: 0 stories19 Nov: 0 stories
Snapshot
Category
GLP-1 receptor agonist 1 source
Intelligence coverage

Ozempic is a glp-1-receptor-agonist medication manufactured by Novo Nordisk 1 used for weight management and glycemic control.

The medication has been the subject of an extended compulsory licensing application 2, a legal mechanism that allows governments to authorize production of patented drugs without the patent holder's consent under specified conditions.

Facts 2

AttributeValueConfidenceSourcesCited
Vendor Novo Nordisk low 1 1
Category GLP-1 receptor agonist low 1 source ↗

Neighbourhood

Developed bySuperseded by Novo NordiskRetatrutide Ozempic

Developed by 1

Superseded by 1

Official links

No official links recorded yet.
Work here? Claim this page with a verified company email or DNS record.

Frequently mentioned together 11

Sources 16

  1. Semaglutide’s heart benefits may partly involve reduced inflammation - News-Medical · Google News: Hacking
  2. video The Economics of Immortality: What Happens If We Live Forever? · Science & Futurism with Isaac Arthur
  3. FDA Warns GLP-1s May Increase Risk of Sudden Blindness · Slashdot
  4. Knee osteoarthritis pain relief – and massive weight loss – from new GLP-1 · New Atlas
  5. video How Food Choices Shape Memory, Cognition & Cravings | Dr. Scott Kanoski · Huberman Lab

Press releases & product news 1

  1. Noom Promo Codes: 50% Off Best Deals for November 2026 · Wired
That's Cyber for today

Tomorrow's desk, in your inbox by 06:00 UTC. The week's best stories, every Sunday. The month that mattered, on the 1st.

Drawn from the 519 sources the paper read this month. Text and HTML, one-click unsubscribe, free.

How often
Your desks